UnitedHealth Group Incorporated $UNH Shares Purchased by Asset Planning Inc

Asset Planning Inc raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,900 shares of the healthcare conglomerate’s stock after acquiring an additional 61 shares during the quarter. Asset Planning Inc’s holdings in UnitedHealth Group were worth $593,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Sivik Global Healthcare LLC grew its position in UnitedHealth Group by 200.0% in the 2nd quarter. Sivik Global Healthcare LLC now owns 15,000 shares of the healthcare conglomerate’s stock valued at $4,680,000 after acquiring an additional 10,000 shares in the last quarter. GFS Advisors LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $4,524,000. Keener Financial Planning LLC boosted its stake in shares of UnitedHealth Group by 411.0% in the 2nd quarter. Keener Financial Planning LLC now owns 373 shares of the healthcare conglomerate’s stock valued at $116,000 after buying an additional 300 shares during the period. Fifth Third Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 5.4% in the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 15,566 shares of the healthcare conglomerate’s stock valued at $4,856,000 after buying an additional 794 shares during the period. Finally, Natural Investments LLC boosted its stake in shares of UnitedHealth Group by 9.4% in the 2nd quarter. Natural Investments LLC now owns 2,514 shares of the healthcare conglomerate’s stock valued at $784,000 after buying an additional 215 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on UNH. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday. Mizuho lifted their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays boosted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, KeyCorp boosted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $354.30 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a 50 day moving average of $318.21 and a two-hundred day moving average of $349.25. The stock has a market cap of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.